PATENT CLAIM ANALYSIS

Application Number: 16118001
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["514", "356000"]

Abstract:
Disclosed herein are methods of treating disease with a combination of a RXR agonist and a thyroid hormone.

Claim (Index 8):
The method according to  claim 1 , wherein the combination of RXR agonist and thyroid hormone treats the nervous system disorder in the individual both by 1) promoting remyelination or neuroprotection of neurons and 2) modulating the individual's immune system.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 96.0
- Lexical Diversity: 1.1875
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15339762', '15812821', '15339752', '14507730', '15988965']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8759515733648212
- 35 USC 102 Novelty (BERT): 0.7003658447710003
- Combined Prediction Score: 0.8583930005054391
- Mean Citation Score: 611.4666759999999
- Max Citation Score: 747.0627
- Similarity Product: 727.9785818033873

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test